Essilor Further Strengthens Its Employee Shareholding, Reaching 65% Globally

Essilor announced that employee shareholding worldwide is expected to reach around 65%, a 10% increase compared with a year ago. More than 45,000 Essilor employees in 58 countries now hold a financial stake in EssilorLuxottica, born following the successful combination of Essilor and Luxottica on October 1st, 2018.

After the success of its employee shareholding plan in 2017, Essilor launched “Boost 2018”, a wider employee share ownership initiative. With a subscription rate at a record level of 66%, the Company’s latest initiative enabled more than 35,000 Essilor employees in over 40 countries to become shareholders of the Group or to increase their participation. The Company has launched an employee shareholding plan every year for the past 30 years.  

Hubert Sagnières, Essilor’s Chairman, declared: “The success of our latest employee shareholding initiative reflects the strong alignment of our employees with our strategy and mission of improving lives by improving sight. Since Essilor’s creation, employee shareholding has been a fundamental pillar of the Group’s culture and central to its unique governance model. Looking ahead, as confirmed during EssilorLuxottica’s first General Meeting, we aim at further expandin gemployees’ involvement in the combined Group’s continuous growth story.”

Click HERE for the full press release.

Featured Posts

CooperVision Appoints Alex Wilkes as President, Americas

CooperVision has named Alex Wilkes as President, Americas, effective June 14. Wilkes brings more than a decade of experience in the eye care industry, having most recently served as Senior Vice President and General Manager of Pearle Vision at Luxottica.

Learn More

Bausch + Lomb Receives Health Canada Approval of LUMIFY® Redness Reliever Eye Drops

LUMIFY® is Canada's First and Only Over-the-Counter Eye Drop with Low-Dose Brimonidine for the Relief of Eye Redness

Read more

Lanvin Unveils New Mother and Child Sunglasses

These feminine sunglasses are designed in an oversized rectangular silhouette, crafted in lightweight acetate.

Read more

A Successful First Half Year for ZEISS

The positive trend continues at the ZEISS Group, which had a positive end to the first six months of fiscal year 2021/22 (ended 31 March 2022) that was significantly higher than the very good result seen in the previous year.

Read more

SILMO Paris 2022: Return to Normalcy

After the successful 2021 reunion, the upcoming edition heralds a return to normalcy and the much-awaited SILMO Paris.

Read more

CooperVision Appoints Alex Wilkes as President, Americas

CooperVision has named Alex Wilkes as President, Americas, effective June 14. Wilkes brings more than a decade of experience in the eye care industry, having most recently served as Senior Vice President and General Manager of Pearle Vision at Luxottica.

Learn More

Bausch + Lomb Receives Health Canada Approval of LUMIFY® Redness Reliever Eye Drops

LUMIFY® is Canada's First and Only Over-the-Counter Eye Drop with Low-Dose Brimonidine for the Relief of Eye Redness

Read More

Lanvin Unveils New Mother and Child Sunglasses

These feminine sunglasses are designed in an oversized rectangular silhouette, crafted in lightweight acetate.

Read More

A Successful First Half Year for ZEISS

The positive trend continues at the ZEISS Group, which had a positive end to the first six months of fiscal year 2021/22 (ended 31 March 2022) that was significantly higher than the very good result seen in the previous year.

Read More

SILMO Paris 2022: Return to Normalcy

After the successful 2021 reunion, the upcoming edition heralds a return to normalcy and the much-awaited SILMO Paris.

Read More

CooperVision Appoints Alex Wilkes as President, Americas

CooperVision has named Alex Wilkes as President, Americas, effective June 14. Wilkes brings more than a decade of experience in the eye care industry, having most recently served as Senior Vice President and General Manager of Pearle Vision at Luxottica.

Learn More

Bausch + Lomb Receives Health Canada Approval of LUMIFY® Redness Reliever Eye Drops

LUMIFY® is Canada's First and Only Over-the-Counter Eye Drop with Low-Dose Brimonidine for the Relief of Eye Redness

Read more

Lanvin Unveils New Mother and Child Sunglasses

These feminine sunglasses are designed in an oversized rectangular silhouette, crafted in lightweight acetate.

Read more

A Successful First Half Year for ZEISS

The positive trend continues at the ZEISS Group, which had a positive end to the first six months of fiscal year 2021/22 (ended 31 March 2022) that was significantly higher than the very good result seen in the previous year.

Read more

SILMO Paris 2022: Return to Normalcy

After the successful 2021 reunion, the upcoming edition heralds a return to normalcy and the much-awaited SILMO Paris.

Read more

CooperVision Appoints Alex Wilkes as President, Americas

CooperVision has named Alex Wilkes as President, Americas, effective June 14. Wilkes brings more than a decade of experience in the eye care industry, having most recently served as Senior Vice President and General Manager of Pearle Vision at Luxottica.

Learn More

Bausch + Lomb Receives Health Canada Approval of LUMIFY® Redness Reliever Eye Drops

LUMIFY® is Canada's First and Only Over-the-Counter Eye Drop with Low-Dose Brimonidine for the Relief of Eye Redness

Read more

Lanvin Unveils New Mother and Child Sunglasses

These feminine sunglasses are designed in an oversized rectangular silhouette, crafted in lightweight acetate.

Read more

A Successful First Half Year for ZEISS

The positive trend continues at the ZEISS Group, which had a positive end to the first six months of fiscal year 2021/22 (ended 31 March 2022) that was significantly higher than the very good result seen in the previous year.

Read more

SILMO Paris 2022: Return to Normalcy

After the successful 2021 reunion, the upcoming edition heralds a return to normalcy and the much-awaited SILMO Paris.

Read more